PRAME and acute myeloid leukemia: To maximize the GvL effect minimizing the risk of GvHD, Lulla et al., selectively activated and expanded stem cell donor-derived T cells reactive to multiple antigens expressed by AML/MDS cells, namely PRAME, WT1, survivin and NY-SEO-1 [62].